MARA HOLDINGS INC (MARA)

US5657881067 - Common Stock

19.3  -0.85 (-4.22%)

After market: 19.3809 +0.08 (+0.42%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to MARA. MARA was compared to 280 industry peers in the Software industry. MARA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. MARA is valued quite expensive, but it does show an excellent growth.



3

1. Profitability

1.1 Basic Checks

In the past year MARA was profitable.
MARA had a negative operating cash flow in the past year.
MARA had negative earnings in 4 of the past 5 years.
MARA had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With an excellent Return On Assets value of 16.01%, MARA belongs to the best of the industry, outperforming 92.83% of the companies in the same industry.
With an excellent Return On Equity value of 20.08%, MARA belongs to the best of the industry, outperforming 88.17% of the companies in the same industry.
Industry RankSector Rank
ROA 16.01%
ROE 20.08%
ROIC N/A
ROA(3y)-15.67%
ROA(5y)-20.67%
ROE(3y)-55.79%
ROE(5y)-53.58%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With an excellent Profit Margin value of 75.04%, MARA belongs to the best of the industry, outperforming 98.57% of the companies in the same industry.
MARA does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 75.04%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

6

2. Health

2.1 Basic Checks

MARA does not have a ROIC to compare to the WACC, probably because it is not profitable.
MARA has more shares outstanding than it did 1 year ago.
The number of shares outstanding for MARA has been increased compared to 5 years ago.
MARA has a better debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 5.02 indicates that MARA is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 5.02, MARA is doing good in the industry, outperforming 61.65% of the companies in the same industry.
MARA has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.22, MARA perfoms like the industry average, outperforming 41.58% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z 5.02
ROIC/WACCN/A
WACC11.5%

2.3 Liquidity

A Current Ratio of 4.00 indicates that MARA has no problem at all paying its short term obligations.
With an excellent Current ratio value of 4.00, MARA belongs to the best of the industry, outperforming 82.44% of the companies in the same industry.
MARA has a Quick Ratio of 4.00. This indicates that MARA is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of MARA (4.00) is better than 82.80% of its industry peers.
Industry RankSector Rank
Current Ratio 4
Quick Ratio 4

7

3. Growth

3.1 Past

MARA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 316.67%, which is quite impressive.
MARA shows a strong growth in Revenue. In the last year, the Revenue has grown by 194.78%.
Measured over the past years, MARA shows a very strong growth in Revenue. The Revenue has been growing by 199.80% on average per year.
EPS 1Y (TTM)316.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-220%
Revenue 1Y (TTM)194.78%
Revenue growth 3Y344.91%
Revenue growth 5Y199.8%
Sales Q2Q%34.54%

3.2 Future

MARA is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -31.30% yearly.
MARA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 40.69% yearly.
EPS Next Y-37.61%
EPS Next 2Y-66.38%
EPS Next 3Y-31.3%
EPS Next 5YN/A
Revenue Next Year73.04%
Revenue Next 2Y57.32%
Revenue Next 3Y40.69%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 24.74, which indicates a rather expensive current valuation of MARA.
Based on the Price/Earnings ratio, MARA is valued a bit cheaper than 76.34% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.55. MARA is around the same levels.
MARA is valuated quite expensively with a Price/Forward Earnings ratio of 205.67.
MARA's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. MARA is more expensive than 62.01% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 24.00. MARA is valued rather expensively when compared to this.
Industry RankSector Rank
PE 24.74
Fwd PE 205.67

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A cheap valuation may be justified as MARA's earnings are expected to decrease with -31.30% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-66.38%
EPS Next 3Y-31.3%

0

5. Dividend

5.1 Amount

MARA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MARA HOLDINGS INC

NASDAQ:MARA (12/26/2024, 8:27:25 PM)

After market: 19.3809 +0.08 (+0.42%)

19.3

-0.85 (-4.22%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)N/A N/A
Inst Owners56.71%
Inst Owner Change0.19%
Ins Owners1.82%
Ins Owner Change-2.86%
Market Cap6.21B
Analysts72.22
Price Target24.67 (27.82%)
Short Float %20.8%
Short Ratio1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-227.51%
Min EPS beat(2)-393.62%
Max EPS beat(2)-61.41%
EPS beat(4)2
Avg EPS beat(4)491.75%
Min EPS beat(4)-393.62%
Max EPS beat(4)1949.6%
EPS beat(8)4
Avg EPS beat(8)266.35%
EPS beat(12)4
Avg EPS beat(12)93.46%
EPS beat(16)5
Avg EPS beat(16)-17.07%
Revenue beat(2)0
Avg Revenue beat(2)-12.38%
Min Revenue beat(2)-14.9%
Max Revenue beat(2)-9.85%
Revenue beat(4)1
Avg Revenue beat(4)-7.11%
Min Revenue beat(4)-14.9%
Max Revenue beat(4)6.67%
Revenue beat(8)2
Avg Revenue beat(8)-8.19%
Revenue beat(12)3
Avg Revenue beat(12)-11.37%
Revenue beat(16)3
Avg Revenue beat(16)-12.41%
PT rev (1m)2.9%
PT rev (3m)9.61%
EPS NQ rev (1m)238.67%
EPS NQ rev (3m)190.85%
EPS NY rev (1m)77.79%
EPS NY rev (3m)45.66%
Revenue NQ rev (1m)-1.25%
Revenue NQ rev (3m)-9.46%
Revenue NY rev (1m)-2.57%
Revenue NY rev (3m)-0.69%
Valuation
Industry RankSector Rank
PE 24.74
Fwd PE 205.67
P/S 8.13
P/FCF N/A
P/OCF N/A
P/B 2.18
P/tB 2.21
EV/EBITDA N/A
EPS(TTM)0.78
EY4.04%
EPS(NY)0.09
Fwd EY0.49%
FCF(TTM)-1.62
FCFYN/A
OCF(TTM)-1.41
OCFYN/A
SpS2.37
BVpS8.87
TBVpS8.73
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 16.01%
ROE 20.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 75.04%
GM N/A
FCFM N/A
ROA(3y)-15.67%
ROA(5y)-20.67%
ROE(3y)-55.79%
ROE(5y)-53.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 18.33%
Cap/Sales 8.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4
Quick Ratio 4
Altman-Z 5.02
F-Score5
WACC11.5%
ROIC/WACCN/A
Cap/Depr(3y)1813.39%
Cap/Depr(5y)1633.27%
Cap/Sales(3y)299.35%
Cap/Sales(5y)558.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)316.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-220%
EPS Next Y-37.61%
EPS Next 2Y-66.38%
EPS Next 3Y-31.3%
EPS Next 5YN/A
Revenue 1Y (TTM)194.78%
Revenue growth 3Y344.91%
Revenue growth 5Y199.8%
Sales Q2Q%34.54%
Revenue Next Year73.04%
Revenue Next 2Y57.32%
Revenue Next 3Y40.69%
Revenue Next 5YN/A
EBIT growth 1Y-286%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2298.38%
EBIT Next 3Y185.96%
EBIT Next 5YN/A
FCF growth 1Y50.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-679.36%
OCF growth 3YN/A
OCF growth 5YN/A